Archive for: Regulatory

Kallelse till årsstämma i Diagonal Bio AB

, , ,
Aktieägarna i Diagonal Bio AB, org.nr 559248-8984, kallas härmed till årsstämma tisdagen den 20 maj 2025 kl. 13.00 på Medicon Village, i huvudbyggnaden The Spark, Scheeletorget 1, Lund.Rätt att delta och anmälanAktieägare…

Diagonal Bio announces additional pilot tests of LAMPlify®

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") is pleased to announce that Diagonal Bio has signed an agreement to conduct pilot tests of the LAMPlify® platform at Stall Törnqvist as well as an undisclosed additional facility.…

Diagonal Bio AB: Diagonal Bio announces additional pilot tests of LAMPlify®

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") is pleased to announce that Diagonal Bio has signed an agreement to conduct pilot tests of the LAMPlify® platform at Stall Törnqvist as well as an undisclosed additional facility.…

Diagonal Bio publishes Year-End Report for 2024

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") hereby publishes its year-end report for the financial year 2024. Below is a brief summary. The full year-end report is available on Diagonal Bio's website (www.diagonalbio.com) and as…

Diagonal Bio AB: Diagonal Bio publishes Year-End Report for 2024

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") hereby publishes its year-end report for the financial year 2024. Below is a brief summary. The full year-end report is available on Diagonal Bio's website (www.diagonalbio.com) and as…

Stall Courant and Diagonal Bio agree to a pilot test of LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") and Stall Courant, owned by Unibet founder Anders Ström and run by trotting trainer Sabine Kagebrant, have signed an agreement regarding a three-month pilot test of the LAMPlify®…

Diagonal Bio has been approved for delisting from Nasdaq First North Growth Market

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") today announces that Nasdaq has approved Diagonal Bio's application for delisting from Nasdaq First North Growth Market (“First North”). The last day of trading on First North…

Diagonal Bio has received conditional approval for listing on NGM Nordic SME

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") has received conditional approval for listing on NGM Nordic SME (“NGM”). The first day of trading is planned for 19 March 2025. This means that Diagonal Bio changes marketplace…

Diagonal Bio applies for change of marketplace to NGM Nordic SME

, , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") today announces that the Company – in order to be able to reallocate costs – has decided to apply for listing on NGM Nordic SME (“NGM”). The decision is based on…

Diagonal Bio AB’s announces last day of trading in BTU and first day of trading in warrants of series TO 2

, , ,
Diagonal Bio AB's ("Diagonal Bio" or the "Company") rights issue of units, with a subscription period ending on 6 February 2025, has now been registered at the Swedish Companies Registration Office together with the directed issue of units which…